You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 29, 2025

List of Excipients in API phentermine hydrochloride


✉ Email this page to a colleague

« Back to Dashboard


Excipients in ANDA-approved (generic) drugs containing phentermine hydrochloride

Detailed excipient profiles for phentermine hydrochloride

Excipient focus: ALCOHOL

Excipient focus: ALUMINUM OXIDE

Excipient focus: AMMONIA

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: BUTYL ALCOHOL

Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS

phentermine hydrochloride drug variants not containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS

Excipient focus: CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE

phentermine hydrochloride drug variants not containing CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: COLLOIDAL SILICON DIOXIDE

Excipient focus: CROSCARMELLOSE SODIUM

phentermine hydrochloride drug variants containing CROSCARMELLOSE SODIUM

Excipient focus: CROSPOVIDONE

Excipient focus: D&C RED NO. 28

Excipient focus: D&C RED NO. 33

Excipient focus: D&C YELLOW NO. 10

Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE

phentermine hydrochloride drug variants containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE

phentermine hydrochloride drug variants not containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE

Excipient focus: DIMETHICONE

Excipient focus: FD&C BLUE NO. 1

phentermine hydrochloride drug variants not containing FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C RED NO. 3

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 5

phentermine hydrochloride drug variants containing FD&C YELLOW NO. 5

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GELATIN

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSES

Excipient focus: ISOPROPYL ALCOHOL

phentermine hydrochloride drug variants containing ISOPROPYL ALCOHOL

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MAIZE INVERT SUGAR

Excipient focus: MANNITOL

Excipient focus: METHYL ALCOHOL

Excipient focus: PEPPERMINT

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYSORBATE 80

Excipient focus: POTASSIUM HYDROXIDE

phentermine hydrochloride drug variants containing POTASSIUM HYDROXIDE

Excipient focus: POVIDONE

Excipient focus: POVIDONE K30

Excipient focus: POVIDONES

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STEARYL FUMARATE

Excipient focus: STARCH, CORN

Excipient focus: STARCH, TAPIOCA

phentermine hydrochloride drug variants containing STARCH, TAPIOCA

Excipient focus: STEARIC ACID

Excipient focus: SUCRALOSE

Excipient focus: SUCROSE

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group